Skip to main content
. 2022 Sep 27;11(1):2315–2325. doi: 10.1080/22221751.2022.2117094

Table 1.

In vitro neutralization potency of CT-P63 against live viruses and pseudoviruses.

  IC50 (ng/mL) Fold change (reduction)
Live viruses    
Wild-type (B.1) 50.50 N/A
Omicron (B.1.1.529.1/BA.1) 96.48 1.91
Omicron (B.1.1.529.2/BA.2) 88.67 1.76
Omicron (BA.2.12.1) 46.95 0.93
Delta (B.1.617.2) 18.88 0.37
Gamma (P.1) 7.21 0.14
Beta (B.1.351) 20.58 0.41
Kappa (B.1.617.1) 25.84 0.51
Alpha (B.1.1.7) 22.46 0.44
Epsilon (B.1.427) 58.48 1.16
Epsilon (B.1.429) 34.28 0.68
Eta (B.1.525) 14.53 0.29
Iota (B.1.526) 44.44 0.88
Zeta (P.2) 31.79 0.63
Pseudoviruses    
D614G 4.81 N/A
Omicron (B.1.1.529.1/BA.1) 22.29 4.63
Omicron (B.1.1.529.2/BA.2) 9.45 1.96
Omicron (BA.2.12.1) 5.46 1.14
Omicron (BA.3) 12.0 2.49
Delta (L452R/T478K/P681R) 5.32 1.11
Gamma (P.1) 1.71 0.36
Beta (B.1.351) 3.27 0.68
Lambda (C.37) 18.69 3.89
Mu (B.1.621) 12.18 2.53
Kappa (L452R/E484Q/P681R) 8.26 1.72
Alpha (B.1.1.7) 4.85 1.01
Epsilon (B.1.427) 14.10 2.93
Epsilon (B.1.429) 5.86 1.22
Eta (B.1.525) 5.57 1.16
Iota (B.1.526) 3.53 0.73
Zeta (P.2) 2.16 0.45

Notes: Fold changes were calculated relative to wild-type live virus or D614G pseudovirus for live viruses and pseudoviruses, respectively.

IC50, half-maximal inhibitory concentration; N/A, not applicable.